SI-BONE, Inc.

NASDAQ:SIBN

Medical - Devices

Healthcare
$23.54 +3.45%

+$0.53 today

Market cap
$1.06B
Beta
0.70
P/E (TTM)
-41.4
EPS (TTM)
-$0.38
52W Low $11.48High $21.89

Volume 1.12M

Average 0.68M

SIBN Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

SI-BONE, Inc.NASDAQ: SIBN

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 43.96M shares rose 3.8% year over year, in line with the +3.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.0% from the prior quarter. Over 3 fiscal years it compounded at +8.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +3.8% holds above the trailing-twelve-month pace of +3.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
43.96M+1.0% QoQ
Last fiscal yearDec 2025
43.51M+4.9% YoY
LTMMar 2026
43.36M+3.6% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.8%——
1 year+4.9%——
3-year CAGR+8.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
43.51M USD
Year-over-year change
+4.9%
4-year CAGR
+7.0%

Weighted Avg Shares vs competitors

How SIBN compares with its peers on the latest reported figures

  • SIBN's LTM Mar 2026 weighted avg shares of 43.36M shares is the 5th highest of the 6 companies compared; the peer median is 151.36M shares.
  • Its year-over-year change of +3.6% is the 2nd highest of 6, against a peer median of -0.0%.
  • Over three fiscal years its annual growth of +8.4% compares with a peer median of +1.1%.
SIBN Competitors Peer median
Weighted Avg Shares for SIBN and competitors
Company Period LTM YoY 3-year CAGR
SNNSmith & Nephew plcFY2025433.42M -1.1%-0.3%
SYKStryker CorporationLTM Jun 2026382.83M +0.3%+0.4%
ATECAlphatec Holdings, Inc.LTM Mar 2026151.36M +5.1%+13.2%
GMEDGlobus Medical, Inc.LTM Jun 2026135.1M -0.7%+10.4%
SIBNSI-BONE, Inc.LTM Mar 202643.36M +3.6%+8.4%
CNMDCONMED CorporationLTM Mar 202630.87M -0.0%+1.1%
Peer median (excluding SIBN) 151.36M-0.0%+1.1%

Competitors are the stored peer set for SIBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue90.15M106.41M138.89M167.18M200.93M
Cost of Revenue10.43M15.71M29.47M35.06M41.05M
Gross Profit79.72M90.7M109.42M132.12M159.88M
Gross Margin88.4%85.2%78.8%79.0%79.6%
Research & Development12.44M13.63M15.03M16.56M17.45M
Selling, General & Admin118.95M136.69M141.32M150.81M164.76M
Operating Expenses131.39M150.31M156.35M167.37M182.21M
Depreciation & Amortization2.09M3.45M5.43M4.38M2.72M
EBITDA(50.97M)(54.99M)(34.45M)(23.09M)(10.91M)
EBITDA Margin-56.5%-51.7%-24.8%-13.8%-5.4%
Operating Income(51.67M)(59.61M)(46.93M)(35.25M)(22.33M)
Operating Margin-57.3%-56.0%-33.8%-21.1%-11.1%
Interest Income186K1.3M6.92M7.85M6.07M
Interest Expense5.37M2.82M3.46M3.44M5.28M
Other Income / Expenses(4.9M)(1.65M)3.6M4.34M3.42M
Income Before Tax(56.57M)(61.26M)(43.34M)(30.91M)(18.91M)
Pre-Tax Margin-62.8%-57.6%-31.2%-18.5%-9.4%
Income Tax Expense00000
Net Income(56.57M)(61.26M)(43.34M)(30.91M)(18.91M)
Net Margin-62.8%-57.6%-31.2%-18.5%-9.4%
EPS (Basic)(1.71)(1.79)(1.13)(0.75)(0.44)
EPS (Diluted)(1.71)(1.79)(1.13)(0.75)(0.44)
Weighted Avg Shares33.15M34.2M38.43M41.47M43.51M
Weighted Avg Shares (Diluted)33.15M34.2M38.43M41.47M43.51M

SI-BONE, Inc.

NASDAQ:SIBN

Intrinsic Alpha fair value

Locked

Current Price

$23.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.